ENTRY       D09733                      Drug
NAME        Afatinib dimaleate (USAN);
            Afatinib maleate (JAN);
            Gilotrif (TN);
            Giotrif (TN)
PRODUCT     GILOTRIF (Boehringer Ingelheim Pharmaceuticals)
FORMULA     C24H25ClFN5O3. (C4H4O4)2
EXACT_MASS  717.1849
MOL_WEIGHT  718.0827
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
               DG03162  EGFR inhibitor
            Transporter substrate
             DG01665  ABCB1 substrate
REMARK      Therapeutic category: 4291
            ATC code: L01EB03
            Chemical structure group: DG00717
            Product (DG00717): D09733<JP/US>
EFFICACY    Antineoplastic, Receptor tyrosine kinase inhibitor
  DISEASE   Non-small cell lung cancer (EGFR mutation positive) [DS:H00014]
TARGET      EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]
            ERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]
            ERBB4 (HER4) [HSA:2066] [KO:K05085]
  PATHWAY   hsa04010(1956+2064+2066)  MAPK signaling pathway
            hsa04012(1956+2064+2066)  ErbB signaling pathway
            hsa05200(1956+2064)  Pathways in cancer
            hsa05223(1956+2064)  Non-small cell lung cancer
METABOLISM  Transporter: ABCB1 [HSA:5243]
INTERACTION  
STR_MAP     map07045  Antineoplastics - protein kinase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
                 L01EB03 Afatinib
                  D09733  Afatinib dimaleate (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Afatinib
                D09733  Afatinib dimaleate (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D09733  Afatinib dimaleate (USAN); Afatinib maleate (JAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03162  EGFR inhibitor
                 DG00717  Afatinib
                  D09733  Afatinib dimaleate
             Transporter substrate
              DG01665  ABCB1 substrate
               DG00717  Afatinib
                D09733  Afatinib dimaleate
            Drug classes [BR:br08332]
             Antineoplastic
              DG03162  EGFR inhibitor
               D09733  Afatinib dimaleate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                EGFR* [HSA_VAR:1956v2]
                 D09733  Afatinib dimaleate (USAN) &lt;JP/US&gt;
                ERBB2 (HER2, CD340)
                 D09733  Afatinib dimaleate (USAN) &lt;JP/US&gt;
                ERBB4 (HER4)
                 D09733  Afatinib dimaleate (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09733
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09733
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09733
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09733
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D09733
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D09733
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03162  EGFR inhibitor
                 DG00717  Afatinib
             Transporter substrate
              DG01665  ABCB1 substrate
               DG00717  Afatinib
DBLINKS     PubChem: 124490473
            ChEBI: 76003
            LigandBox: D09733
ATOM        50
            1   C2b C    26.0737  -14.3060
            2   C2b C    27.4759  -14.3060
            3   C6a C    25.3727  -15.5202
            4   O6a O    23.9707  -15.5202
            5   O6a O    26.0641  -16.7175
            6   C6a C    28.1769  -15.5202
            7   O6a O    29.5788  -15.5202
            8   O6a O    27.4855  -16.7175
            9   C8x C     6.5739  -14.4223
            10  N5x N     6.5739  -15.8855
            11  C8y C     7.8281  -16.5823
            12  C8y C     9.0822  -15.8855
            13  C8y C     9.0822  -14.4223
            14  N5x N     7.8281  -13.7255
            15  C8x C    10.2667  -16.5823
            16  C8y C    11.4512  -15.8855
            17  C8y C    11.4512  -14.4223
            18  C8x C    10.2667  -13.7255
            19  N1b N     7.8281  -17.9758
            20  C8y C     9.0822  -18.6725
            21  C8x C     9.0822  -19.9964
            22  C8y C    10.2667  -20.6931
            23  C8y C    11.4512  -19.9964
            24  C8x C    11.4512  -18.6725
            25  C8x C    10.2667  -17.9758
            26  X   F    12.7054  -20.6931
            27  X   Cl   10.2667  -22.1563
            28  N1b N    12.6357  -16.5126
            29  C5a C    13.8202  -15.8158
            30  C2b C    15.0047  -16.5126
            31  O5a O    13.8202  -14.4223
            32  C2b C    16.1892  -15.8158
            33  C1b C    17.3737  -16.5126
            34  N1c N    18.5582  -15.8158
            35  C1a C    19.7427  -16.5126
            36  C1a C    18.5582  -14.4223
            37  O2a O    12.6357  -13.7952
            38  C1y C    12.6357  -12.4017
            39  C1x C    13.8202  -11.4959
            40  C1x C    13.3325  -10.1721
            41  O2x O    11.9390  -10.1721
            42  C1x C    11.4512  -11.4959
            43  C2b C    26.0737  -14.3060
            44  C2b C    27.4759  -14.3060
            45  C6a C    28.1769  -15.5202
            46  O6a O    29.5788  -15.5202
            47  O6a O    27.4855  -16.7175
            48  C6a C    25.3727  -15.5202
            49  O6a O    23.9707  -15.5202
            50  O6a O    26.0641  -16.7175
BOND        51
            1     9  10 1
            2    10  11 2
            3    11  12 1
            4    12  13 1
            5    13  14 1
            6     9  14 2
            7    12  15 2
            8    15  16 1
            9    16  17 2
            10   17  18 1
            11   13  18 2
            12   11  19 1
            13   19  20 1
            14   20  21 2
            15   21  22 1
            16   22  23 2
            17   23  24 1
            18   24  25 2
            19   20  25 1
            20   23  26 1
            21   22  27 1
            22   16  28 1
            23   28  29 1
            24   29  30 1
            25   29  31 2
            26   30  32 2
            27   32  33 1
            28   33  34 1
            29   34  35 1
            30   34  36 1
            31   17  37 1
            32   38  37 1 #Down
            33   38  39 1
            34   39  40 1
            35   40  41 1
            36   41  42 1
            37   38  42 1
            38    1   2 2
            39    1   3 1
            40    3   4 1
            41    3   5 2
            42    2   6 1
            43    6   7 2
            44    6   8 1
            45   43  44 2
            46   43  48 1
            47   48  49 1
            48   48  50 2
            49   44  45 1
            50   45  46 2
            51   45  47 1
BRACKET     1    22.3300  -18.2700   22.3300  -13.3700
            1    30.5200  -13.3700   30.5200  -18.2700
            1  2
  ORIGINAL  1    1   2   6   7   8   3   4   5
  REPEAT    1   43  44  45  46  47  48  49  50
///
